Paul Alpern Sells 8,309 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) VP Paul Alpern sold 8,309 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $15.45, for a total value of $128,374.05. Following the completion of the sale, the vice president owned 61,968 shares in the company, valued at approximately $957,405.60. This represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Arteris Stock Down 0.9%

Shares of NASDAQ AIP opened at $17.42 on Thursday. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $19.85. The firm’s 50-day simple moving average is $15.27 and its 200 day simple moving average is $12.05. The company has a market cap of $760.91 million, a price-to-earnings ratio of -20.99 and a beta of 1.48.

Arteris (NASDAQ:AIP) last released its earnings results on Tuesday, November 4th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.02. The business had revenue of $17.41 million for the quarter, compared to analyst estimates of $17.00 million. On average, equities analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Westerly Capital Management LLC raised its holdings in Arteris by 109.6% during the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock valued at $14,392,000 after acquiring an additional 745,000 shares during the period. Granahan Investment Management LLC grew its position in shares of Arteris by 725.7% in the third quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock valued at $6,278,000 after purchasing an additional 546,341 shares in the last quarter. Acadian Asset Management LLC raised its stake in shares of Arteris by 40.6% during the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company’s stock valued at $6,222,000 after purchasing an additional 260,277 shares during the period. AQR Capital Management LLC purchased a new stake in Arteris during the 1st quarter worth about $1,621,000. Finally, Roubaix Capital LLC purchased a new stake in Arteris during the 3rd quarter worth about $2,361,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Key Headlines Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Several institutional investors increased or initiated positions (AQR, Acadian, Jacobs Levy, IEQ), signaling continued institutional interest that can support the stock. MarketBeat: Arteris overview
• Neutral Sentiment: Recent quarterly results: Arteris reported EPS of ($0.09) vs. consensus ($0.11) and revenue $17.41M vs. $17.00M — a small beat that supports fundamentals but the company remains unprofitable on a GAAP basis. Analysts have a consensus target ~ $17.50 (Moderate Buy). MarketBeat: Earnings & analyst notes
• Neutral Sentiment: Technical/context: AIP is trading above its 50-day ($15.20) and 200-day ($12.01) moving averages, which can limit downside for some technical traders. MarketBeat: Price data
• Negative Sentiment: Heavy insider selling this week: CEO K. Charles Janac, COO Laurent Moll, CFO Nicholas Hawkins and VP Paul Alpern sold multiple blocks (several thousand shares each) at prices roughly $15.45–$16.89 across Jan. 2–6. Collective insider sales reduce insider ownership and can be interpreted negatively by the market even though insiders still hold sizable stakes. InsiderTrades: Jan 7 summary

Analysts Set New Price Targets

A number of brokerages recently weighed in on AIP. Wall Street Zen upgraded shares of Arteris from a “sell” rating to a “hold” rating in a report on Monday, September 15th. Rosenblatt Securities reissued a “buy” rating and issued a $20.00 target price on shares of Arteris in a report on Monday, December 15th. Jefferies Financial Group raised Arteris to a “hold” rating in a research note on Tuesday, October 28th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, October 8th. Finally, TD Cowen boosted their price objective on shares of Arteris from $15.00 to $16.50 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $17.50.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.